Founder & CEO Beth Hoffman describes how Origami’s platform is different than other degrades like PROTACs, and how it specifically is designed to clear the mutant huntingtin protein. Plus, details on a global collaboration announced earlier this year with Ipsen.

Watch Interview


Warning: Invalid argument supplied for foreach() in /home/origam10/public_html/wp-content/plugins/gdpr-cookie-consent/public/templates/cookie-notice.php on line 133